Abstract: Embodiments of the present disclosure relate to methods of using bupivacaine multivesicular liposomes as stellate ganglion block for treating or ameliorating an anxiety disorder or a traumatic brain injury associated with overactive or unbalanced sympathetic nervous system, including but not limited to, generalized anxiety disorders, panic disorder, and post-traumatic stress disorder.

Abstract: A voltage discharge device configured to drain a voltage of one or more energy storage devices by adaptively adjusting an internal resistance based on a voltage of the one or more energy storage devices. The internal resistance may be selectively adjusted using a plurality of transistors coupled to a resistor coil disposed in the voltage discharge device.

Abstract: A security device includes an array of lenses and a plurality of first and second segments disposed under the array of lenses. At a first viewing angle, the array of lenses presents a first image for viewing without presenting the second image for viewing, and at a second viewing angle different from the first viewing angle, the array of lenses presents for viewing the second image without presenting the first image for viewing. At least one first or second segment can include one or more microstructures or one or more nanostructures configured to produce one or more colors for the first or second image.

Abstract: The present invention discloses a one piece corner fitting for a corner section of an eaves trough. The corner fitting of the present invention includes two arms designed to substantially fit within the corner section of the eaves trough, each arm including a back side wall configured to lie substantially adjacent a back side wall of the eaves trough corner section, a front side wall configured to lie substantially adjacent a front side wall of the eaves trough corner section and a bottom surface extending between the back side wall and the front side wall of the corner fitting, said back side wall front side wall and bottom surface forming a channel.

Abstract: Compositions and methods for diagnosing and treating CVH and CVH-associated disorders are disclosed. Genes differentially expressed in CVH tissues relative to normal tissues are identified. The genes and the gene products (i.e., the polynucleotides transcribed from and polypeptides encoded by the genes) can be used as markers of CVH. The genes and the gene products can also be used to screen agents that modulate the gene expression or the activities of the gene products.

Abstract: A treatment to differentially regulate the expression of genes related to irritable bowel syndrome is provided.

Abstract: The invention provides a method and software for use within audio and video authoring software applications wherein the relationships between the source media files are saved and used as part of a media manager. The software allows the artist to efficiently recall which files were used together, as well as how they were used together musically or visually.

Abstract: The invention provides a method of decreasing pain in a subject, the method comprising administering to the subject an amount of a compound effective to decrease activation of protease activated receptor-2.

Abstract: Compositions and methods for diagnosing and treating CVH and CVH-associated disorders are disclosed. Genes differentially expressed in CVH tissues relative to normal tissues are identified. The genes and the gene products (i.e., the polynucleotides transcribed from and polypeptides encoded by the genes) can be used as markers of CVH. The genes and the gene products can also be used to screen agents that modulate the gene expression or the activities of the gene products.

Abstract: This invention concerns the delivery of anti-parasitic agents to ruminant animals. More particularly, the invention concerns delivery of such agents in a controlled manner to enable the agent to have maximum effect on the parasite for longer times than is possible with conventional formulations. The composition of the invention comprises a benzimidazole, macrocyclic lactone, organophosphate, salicylanilide/substituted phenol, tetramisole or pyrimidine anti-parasitic agent dispersed in a medium the solubility characteristics of which are such as to ensure that, following oral administration, controlled amounts of the anti-parasitic agent become available to the parasite, either directly or by absorption into the ruminant blood plasma, during passage of the composition through the rumen, the abomasum and the intestine.

Abstract: A product adapted for the treatment of cellulosic fabric comprises a container having at least two compartments for holding two or more fluent substances separate from one another but adapted for dispensing the substances simultaneously, and having in one compartment a resin precondensate and in another compartment a latent acid catalyst. The product is used to make aqueous solutions of both resin precondensates and latent acid catalysts for fabric treatment, whilst keeping the ingredients separate until required for use.